Humanigen Inc (HGENQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
Humanigen Cash and Short Term Investments (Quarterly): 3.096M for March 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 3.096M |
| December 31, 2022 | 10.16M |
| September 30, 2022 | 24.72M |
| June 30, 2022 | 47.05M |
| March 31, 2022 | 68.95M |
| December 31, 2021 | 70.02M |
| September 30, 2021 | 76.50M |
| June 30, 2021 | 120.54M |
| March 31, 2021 | 92.89M |
| December 31, 2020 | 67.74M |
| September 30, 2020 | 91.43M |
| June 30, 2020 | 41.73M |
| March 31, 2020 | 0.068M |
| December 31, 2019 | 0.143M |
| September 30, 2019 | 0.157M |
| June 30, 2019 | 1.091M |
| March 31, 2019 | 0.18M |
| December 31, 2018 | 0.814M |
| September 30, 2018 | 2.038M |
| June 30, 2018 | 0.267M |
| March 31, 2018 | 1.56M |
| December 31, 2017 | 0.737M |
| September 30, 2017 | 1.095M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.103M |
| March 31, 2017 | 4.041M |
| December 31, 2016 | 2.906M |
| September 30, 2016 | 2.905M |
| June 30, 2016 | 11.94M |
| March 31, 2016 | 6.577M |
| December 31, 2015 | 8.431M |
| September 30, 2015 | 7.65M |
| June 30, 2015 | 23.03M |
| March 31, 2015 | 30.22M |
| December 31, 2014 | 40.71M |
| September 30, 2014 | 49.11M |
| June 30, 2014 | 58.03M |
| March 31, 2014 | 62.70M |
| December 31, 2013 | 76.73M |
| September 30, 2013 | 54.94M |
| June 30, 2013 | 63.65M |
| March 31, 2013 | 76.85M |
| December 31, 2012 | 20.30M |
| September 30, 2012 | 24.74M |
| June 30, 2012 | 27.51M |
| December 31, 2011 | 17.85M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.068M
Minimum
Mar 2020
120.54M
Maximum
Jun 2021
44.77M
Average
44.39M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cannabis Global Inc | 0.2534M |
| Item 9 Labs Corp | 0.1834M |
| Cantabio Pharmaceuticals Inc | 0.2834M |
| Affymax Inc | -- |
| Statera BioPharma Inc | 0.5061M |